Skip to main content
. 2020 Aug 19;13(2):997–1001. doi: 10.1159/000508948

Table 1.

Course, dose, and success of drug therapy

Initiation of therapy Therapy Dose, mg Therapeutic effect
2010 Pregabalin Amitriptyline 150-0-300
0-0-75
NRS 5/10

April 2014
(first presentation)
Pregabalin Amitriptyline Duloxetine 300-0-300
0-0-75
30-0-0
Discontinued by patient due to intolerance

May 2014 Pregabalin Amitriptyline Tapentadol 300-0-300
0-0-75
50-0-50, increased from the third day on 100-0-100
NRS 5/10
Initiation of therapy due to severe pain

July 2014 Pregabalin
Amitriptyline
Tapentadol
150-0-150
0-0-75
150-0-150
Dose increase due to persistent pain

September 2014 (begin capsaicin 8%) Capsaicin 8% Pregabalin Amitriptyline Tapentadol 1 patch; 30 min
150-0-150
0-0-50
150-0-150
NRS 3–4/10
Hyperesthesia ↓ Allodynia ↓↓↓

Since August 2015 Capsaicin 8%
Pregabalin
Amitriptyline
Tapentadol
1-2 patches; 30 min; every third month,
18 treatments in total
150-0-150
0-0-50
150-0-150